BIOMAT Database Logo BIOMAT Database Logo

Synthesis of AZT 5'-triphosphate mimics and their inhibitory effects on HIV-1 reverse transcriptase. 2004

Guangyi Wang, and Nicholas Boyle, and Fu Chen, and Vasanthakumar Rajappan, and Patrick Fagan, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Vivek K Rajwanshi, and Yi Jin, and Marija Prhavc, and Thomas W Bruice, and P Dan Cook
Research Laboratories, Biota, Inc., 2232 Rutherford Road, Carlsbad, CA 92008, USA. g.wang@biota-inc.com

In search of active nucleoside 5'-triphosphate mimics, we have synthesized a series of AZT triphosphate mimics (AZT P3Ms) and evaluated their inhibitory effects on HIV-1 reverse transcriptase as well as their stability in fetal calf serum and in CEM cell extracts. Reaction of AZT with 2-chloro-4H-1,3,2-benzodioxaphosphorin-4-one, followed by treatment of the phosphite intermediate 2 with pyrophosphate analogues, yielded the cyclic triphosphate intermediates 4b-4f, which were subjected to boronation and subsequent hydrolysis to give AZT 5'-alpha-borano-beta,gamma-bridge-modified triphosphates 6b-6f in moderate to good yields. Reaction of the cyclic intermediate 4d with iodine, followed by treatment with a series of nucleophiles, afforded the AZT 5'-beta,gamma-difluoromethylene-gamma-substituted triphosphates (7b-7i). Several different types of AZT P3Ms containing alpha-P-thio (or dithio) and beta,gamma-difluoromethylene (13,14), alpha,beta-difluoromethylene and gamma-P-methyl(or phenyl) (15,16), and alpha-borano-beta,gamma-difluoromethylene and gamma-O-methyl/phenyl (11,12) were also synthesized. The effectiveness of the compounds as inhibitors of HIV-1 reverse transcriptase was determined using a fluorometric assay and a poly(A) homopolymer as a template. A number of AZT P3Ms exhibited very potent inhibition of HIV-1 reverse transcriptase. Modifications at the beta,gamma-bridge of triphosphate rendered the AZT P3Ms 6b-6f with varied activities (K(i) from 9.5 to >>500 nM) while modification at the alpha,beta-bridge of triphosphate led to weak AZT P3M inhibitors. The results imply that the AZT P3Ms were substrate inhibitors, as is AZT triphosphate. The most active compound, AZT 5'-alpha-R(p)()-borano-beta,gamma-(difluoromethylene)triphosphate (AZT 5'-alphaB-betagammaCF(2)TP) (6d-I), is as potent as AZT triphosphate with a K(i)() value of 9.5 nM and at least 20-fold more stable than AZT triphosphate in the serum and cell extracts. Therefore, for the first time, a highly active and stable nucleoside triphosphate mimic has been identified, which is potentially useful as a new type of antiviral drug. The promising triphosphate mimic, 5'-alpha-borano-beta,gamma-(difluoromethylene)triphosphate, is expected to be valuable to the discovery of nucleotide mimic antiviral drugs.

UI MeSH Term Description Entries
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

Guangyi Wang, and Nicholas Boyle, and Fu Chen, and Vasanthakumar Rajappan, and Patrick Fagan, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Vivek K Rajwanshi, and Yi Jin, and Marija Prhavc, and Thomas W Bruice, and P Dan Cook
Synthesis of 5'-triphosphate mimics (P3Ms) of 3'-azido-3',5'-dideoxythymidine and 3',5'-dideoxy-5'-difluoromethylenethymidine as HIV-1 reverse transcriptase inhibitors.
January 2005, Nucleosides, nucleotides & nucleic acids,
Guangyi Wang, and Nicholas Boyle, and Fu Chen, and Vasanthakumar Rajappan, and Patrick Fagan, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Vivek K Rajwanshi, and Yi Jin, and Marija Prhavc, and Thomas W Bruice, and P Dan Cook
Non-nucleoside inhibitors of HIV-1 reverse transcriptase inhibit phosphorolysis and resensitize the 3'-azido-3'-deoxythymidine (AZT)-resistant polymerase to AZT-5'-triphosphate.
October 2003, The Journal of biological chemistry,
Guangyi Wang, and Nicholas Boyle, and Fu Chen, and Vasanthakumar Rajappan, and Patrick Fagan, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Vivek K Rajwanshi, and Yi Jin, and Marija Prhavc, and Thomas W Bruice, and P Dan Cook
Inhibitory effects of 2'-deoxy-5-styryluridine 5'-triphosphate analogs on retroviral reverse transcriptase and eukaryotic DNA polymerases.
January 1992, Nucleic acids symposium series,
Guangyi Wang, and Nicholas Boyle, and Fu Chen, and Vasanthakumar Rajappan, and Patrick Fagan, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Vivek K Rajwanshi, and Yi Jin, and Marija Prhavc, and Thomas W Bruice, and P Dan Cook
Synthesis and anti-HIV activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] dimers as potential multifunctional inhibitors of HIV-1 reverse transcriptase.
May 1995, Journal of medicinal chemistry,
Guangyi Wang, and Nicholas Boyle, and Fu Chen, and Vasanthakumar Rajappan, and Patrick Fagan, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Vivek K Rajwanshi, and Yi Jin, and Marija Prhavc, and Thomas W Bruice, and P Dan Cook
Interactions of the HIV-1 reverse transcriptase 'AZT-resistant' mutant with substrates and AZT-TP.
July 1993, FEBS letters,
Guangyi Wang, and Nicholas Boyle, and Fu Chen, and Vasanthakumar Rajappan, and Patrick Fagan, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Vivek K Rajwanshi, and Yi Jin, and Marija Prhavc, and Thomas W Bruice, and P Dan Cook
Synthesis of quinolin-2-one alkaloid derivatives and their inhibitory activities against HIV-1 reverse transcriptase.
September 2011, Molecules (Basel, Switzerland),
Guangyi Wang, and Nicholas Boyle, and Fu Chen, and Vasanthakumar Rajappan, and Patrick Fagan, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Vivek K Rajwanshi, and Yi Jin, and Marija Prhavc, and Thomas W Bruice, and P Dan Cook
Inhibitory effect of N3-methyl derivative of 3'-azido-3'-deoxythymidine 5'-triphosphate on the activity of HIV-1 reverse transcriptase.
January 1991, Nucleic acids symposium series,
Guangyi Wang, and Nicholas Boyle, and Fu Chen, and Vasanthakumar Rajappan, and Patrick Fagan, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Vivek K Rajwanshi, and Yi Jin, and Marija Prhavc, and Thomas W Bruice, and P Dan Cook
Template-competitive inhibitors of HIV-1 reverse transcriptase: design, synthesis and inhibitory activity.
March 2002, Bioorganic & medicinal chemistry,
Guangyi Wang, and Nicholas Boyle, and Fu Chen, and Vasanthakumar Rajappan, and Patrick Fagan, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Vivek K Rajwanshi, and Yi Jin, and Marija Prhavc, and Thomas W Bruice, and P Dan Cook
Synthesis and evaluation of "AZT-HEPT", "AZT-pyridinone", and "ddC-HEPT" conjugates as inhibitors of HIV reverse transcriptase.
May 2000, Journal of medicinal chemistry,
Guangyi Wang, and Nicholas Boyle, and Fu Chen, and Vasanthakumar Rajappan, and Patrick Fagan, and Jennifer L Brooks, and Tiffany Hurd, and Janet M Leeds, and Vivek K Rajwanshi, and Yi Jin, and Marija Prhavc, and Thomas W Bruice, and P Dan Cook
Data on synthesis of methylene bisphosphonates and screening of their inhibitory activity towards HIV reverse transcriptase.
September 2016, Data in brief,
Copied contents to your clipboard!